A 24-week treatment with bofanglutide for patients with type 2 diabetes showed meaningful glycemic control, weight loss, and improvements in cardiometabolic risk factors — reductions which seemed at ...

HHS terminates COVID-19 Emergency Use Authorizations for drugs, biologics, and devices, establishing transition timelines toward traditional FDA pathways.

Metformin does not significantly reduce the risk for long COVID at 6 months in low-risk adults with high baseline immunity to the virus.

Survivors of hematologic cancers face a higher risk of developing cardiovascular disease, according to study results.

Better maternal CVH is associated with lower risk for offspring developmental delay at age 4 years, according to study results.

Younger adults are more susceptible to asymptomatic rhinovirus infections, whereas older adults are more likely to experience respiratory symptoms.

A surge in tetracycline resistance reduces the clinical benefit of doxycycline PEP against gonorrhea in high-risk populations.

The CDC released updated operational guidance for investigating locally-acquired mosquito-transmitted malaria in the US.

Among well-appearing febrile infants aged 60 to 90 days in emergency department (ED) or outpatient settings, 1.11% have an invasive bacterial infection (IBI), mostly bacteremia, a ...

An FDA panel voted 9-0 that the benefits of Moderna’s mRNA-1010 flu vaccine outweigh risks for adults aged 50 and older.

Experts say warmer weather may be helping a rare, dangerous tick-borne virus called Powassan spread across the US.

Genetically predicted lower systolic blood pressure is associated with an increased susceptibility to allergic rhinitis.